These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
67 related items for PubMed ID: 3208362
21. Establishment of two human renal cell carcinoma cell lines with different chemosensitivity. Naito S, Kotoh S, Goto K, Koga H, Hasegawa S, Noma H, Yamasaki T, Kumazawa J. Hum Cell; 1996 Jun; 9(2):101-8. PubMed ID: 9183637 [Abstract] [Full Text] [Related]
22. [Characteristics of an established human renal cell carcinoma heterotransplanted to nude mice and lectin binding studies]. Shirahama T, Ohi Y. Nihon Hinyokika Gakkai Zasshi; 1988 Feb; 79(2):309-15. PubMed ID: 3226007 [No Abstract] [Full Text] [Related]
23. [Establishment and characterization of a cell line (KO-RCC-1) from a human renal cell carcinoma]. Okada Y, Gohji K, Kamidono S, Tachiwaki O. Nihon Hinyokika Gakkai Zasshi; 1986 May; 77(5):780-5. PubMed ID: 3747314 [No Abstract] [Full Text] [Related]
24. [Establishment of the new cell lines derived from the human renal cell carcinoma and study of the sensitivity test of anti-cancer drugs to cell lines]. Hayashi N, Sugimura Y, Sakurai M, Tochigi H, Kawamura J. Nihon Hinyokika Gakkai Zasshi; 1989 Jan; 80(1):59-68. PubMed ID: 2724746 [Abstract] [Full Text] [Related]
25. Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma. Gerharz CD, Moll R, Störkel S, Ramp U, Hildebrandt B, Molsberger G, Koldovsky P, Gabbert HE. Am J Pathol; 1995 Apr; 146(4):953-62. PubMed ID: 7717462 [Abstract] [Full Text] [Related]
26. New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data. Debruyne FM, Franssen MP, Beniers AJ, Schalken JA, de Mulder PH. Prog Clin Biol Res; 1990 Apr; 350():243-55. PubMed ID: 2117284 [No Abstract] [Full Text] [Related]
27. Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival. Zhang Y, Li J, Song Y, Chen F, Pei Y, Yao F. Mol Med Rep; 2014 Aug; 10(2):860-6. PubMed ID: 24913320 [Abstract] [Full Text] [Related]
29. Stability of human renal cell carcinomas during long term serial transplantation into nude mice: histopathology, nuclear grade, mitotic rate, and DNA content in thirty tumors. Knöfel WT, Otto U, Baisch H, Klöppel G. Cancer Res; 1987 Jan 01; 47(1):221-4. PubMed ID: 3791208 [Abstract] [Full Text] [Related]
30. A study on direct antitumor activity of bropirimine (oral interferon inducer) for renal cell carcinoma. Onishi T, Machida T. Hinyokika Kiyo; 1994 Mar 01; 40(3):195-200. PubMed ID: 8178735 [Abstract] [Full Text] [Related]
31. [Ki-67 antisense therapy in murine renal cell carcinoma models]. Kausch I, Jiang H, Brocks C, Albers A, Krüger S, Sczakiel G, Jocham D. Aktuelle Urol; 2005 Apr 01; 36(2):142-8. PubMed ID: 15902575 [Abstract] [Full Text] [Related]
32. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway. Ji SQ, Su XL, Cheng WL, Zhang HJ, Zhao YQ, Han ZX. Urol Oncol; 2014 Feb 01; 32(2):153-61. PubMed ID: 23273913 [Abstract] [Full Text] [Related]
33. Comments on 'In vivo selection of human renal carcinoma cells with high metastatic potenital in nude mice'. Weiss L. Clin Exp Metastasis; 1990 Feb 01; 8(1):103-9. PubMed ID: 2293910 [No Abstract] [Full Text] [Related]
34. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential. Miyake H, Hara I, Yoshimura K, Eto H, Arakawa S, Wada S, Chihara K, Kamidono S. Cancer Res; 1996 May 15; 56(10):2440-5. PubMed ID: 8625325 [Abstract] [Full Text] [Related]
35. Induction of transplantable mouse renal cell cancers by streptozotocin: in vivo growth, metastases, and angiogenic phenotype. Gruys ME, Back TC, Subleski J, Wiltrout TA, Lee JK, Schmidt L, Watanabe M, Stanyon R, Ward JM, Wigginton JM, Wiltrout RH. Cancer Res; 2001 Aug 15; 61(16):6255-63. PubMed ID: 11507080 [Abstract] [Full Text] [Related]
36. [Establishment of cell lines (KH-39, KN-41, and KW-103) from human kidney and bladder cancer and their characteristics]. Naito K, Hisazumi H, Kanokogi M, Katoh M, Nakazima K, Tsukahara K, Kobayashi T, Kuroda K, Matsubara F. Nihon Hinyokika Gakkai Zasshi; 1982 Aug 15; 73(8):1019-31. PubMed ID: 7154478 [No Abstract] [Full Text] [Related]
37. Prognostic relevance of the intrinsic growth deceleration of the first passage xenografts of human renal cell carcinomas. Bassukas ID, Hofmockel G, Tsatalpas P, Eberle V, Maurer-Schultze B. Cancer; 1996 Nov 15; 78(10):2170-2. PubMed ID: 8918411 [Abstract] [Full Text] [Related]
38. Tumor site-dependent differential modulation of systemic immunity in RENCA bearing mice. Yoon HL, Choi KM, Jung YS, Park CH, Yoon SS. In Vivo; 1999 Nov 15; 13(5):407-13. PubMed ID: 10654194 [Abstract] [Full Text] [Related]
39. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice. Uchida T, Gao JP, Wang C, Satoh T, Itoh I, Muramoto M, Hyodo T, Irie A, Akahoshi T, Jiang SX, Kameya T, Baba S. Mol Urol; 2001 Nov 15; 5(2):71-8. PubMed ID: 11690551 [Abstract] [Full Text] [Related]
40. Spontaneous regression of primary renal cell carcinoma--a case report. Choi SK, Chang SK, Lee JM, Jung WH, Park CI. Yonsei Med J; 1986 Nov 15; 27(4):314-7. PubMed ID: 3564545 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]